Tarbox Family Office’s Medpace MEDP Stock Holding History

Tarbox Family Office’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-44	Closed	-$4K	–	1188
2020 Q2	$4K	Hold	44	–	–	﹤0.01%	533
2020 Q1	$3K	Buy	+44	New	+$3.82K	﹤0.01%	540

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Tarbox Family Office's MEDP Position: Q3 2020 in Review

Tarbox Family Office sold out of Medpace (MEDP) in Q3 2020, closing a stake of 44 shares — an estimated $4K sold.

Tarbox Family Office first reported a position in MEDP in Q1 2020 and held it in 2 quarters. The position peaked at $4K in Q2 2020. 310 funds tracked by Wall St. Rank hold MEDP as of Q3 2020.

Tarbox Family Office reported no remaining Medpace position as of Q3 2020 after selling out during the quarter.
Tarbox Family Office sold 44 Medpace shares in Q3 2020, an estimated $4K.
Tarbox Family Office first reported a position in Medpace in Q1 2020 and held it in 2 quarters.
Tarbox Family Office's Medpace position peaked at $4K in Q2 2020.
310 funds tracked by Wall St. Rank held Medpace as of Q3 2020.

Based on Tarbox Family Office's 13F filing for Q3 2020, filed 22 Oct 2020.